These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 22941872

  • 1. Effects of hemodialysis and vitamin E supplementation on low-density lipoprotein oxidizability in end-stage renal failure.
    Baldi S, Innocenti M, Frascerra S, Nannipieri M, Lippi A, Rindi P, Ferrannini E.
    J Nephrol; 2013; 26(3):549-55. PubMed ID: 22941872
    [Abstract] [Full Text] [Related]

  • 2. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy.
    Islam KN, O'Byrne D, Devaraj S, Palmer B, Grundy SM, Jialal I.
    Atherosclerosis; 2000 May; 150(1):217-24. PubMed ID: 10781654
    [Abstract] [Full Text] [Related]

  • 3. Vitamin E supplementation increases LDL resistance to ex vivo oxidation in hemodialysis patients.
    Badiou S, Cristol JP, Morena M, Bosc JY, Carbonneau MA, Dupuy AM, Descomps B, Canaud B.
    Int J Vitam Nutr Res; 2003 Jul; 73(4):290-6. PubMed ID: 12951902
    [Abstract] [Full Text] [Related]

  • 4. Increased susceptibility of LDL to in vitro oxidation in patients on maintenance hemodialysis: effects of fish oil and vitamin E administration.
    Panzetta O, Cominacini L, Garbin U, Fratta Pasini A, Gammaro L, Bianco F, Davoli A, Campagnola M, De Santis A, Pastorino AM.
    Clin Nephrol; 1995 Nov; 44(5):303-9. PubMed ID: 8605710
    [Abstract] [Full Text] [Related]

  • 5. Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy.
    O'Byrne D, Devaraj S, Islam KN, Collazo R, McDonald L, Grundy S, Jialal I.
    Metabolism; 2001 Feb; 50(2):207-15. PubMed ID: 11229431
    [Abstract] [Full Text] [Related]

  • 6. Lipoperoxidation and hemodialysis.
    Ramos R, Martínez-Castelao A.
    Metabolism; 2008 Oct; 57(10):1369-74. PubMed ID: 18803940
    [Abstract] [Full Text] [Related]

  • 7. [Lipoprotein oxidation profile in end stage renal disease patients. Role of vitamin C supplementation].
    Ramos R, Gómez-Geriqué N, Martínez-Castelao A.
    Nefrologia; 2005 Oct; 25(2):178-84. PubMed ID: 15912655
    [Abstract] [Full Text] [Related]

  • 8. Regional variations of low-density lipoprotein oxidizability in hemodialysis patients may explain discrepancies in interventional therapy on oxidative profile.
    Morena M, Gausson V, Mothu N, Bouchet JL, Chanas M, Grandvuillemin M, Robert A, Vela C, Canaud B, Cristol JP, Olmer M.
    Blood Purif; 2008 Oct; 26(3):300-10. PubMed ID: 18451643
    [Abstract] [Full Text] [Related]

  • 9. Oxidative stress in patients with end-stage renal disease prior to the start of renal replacement therapy.
    Diepeveen SH, Verhoeven GH, van der Palen J, Dikkeschei BL, van Tits LJ, Kolsters G, Offerman JJ, Bilo HJ, Stalenhoef AF.
    Nephron Clin Pract; 2004 Oct; 98(1):c3-7. PubMed ID: 15361698
    [Abstract] [Full Text] [Related]

  • 10. Protective effects of high-density lipoprotein against oxidative stress are impaired in haemodialysis patients.
    Morena M, Cristol JP, Dantoine T, Carbonneau MA, Descomps B, Canaud B.
    Nephrol Dial Transplant; 2000 Mar; 15(3):389-95. PubMed ID: 10692526
    [Abstract] [Full Text] [Related]

  • 11. Vitamin E-bonded hemodialyzer improves neutrophil function and oxidative stress in patients with end-stage renal failure.
    Tsuruoka S, Kawaguchi A, Nishiki K, Hayasaka T, Fukushima C, Sugimoto K, Saito T, Fujimura A.
    Am J Kidney Dis; 2002 Jan; 39(1):127-33. PubMed ID: 11774111
    [Abstract] [Full Text] [Related]

  • 12. Oxidized low-density lipoproteins and endothelium: oral vitamin E supplementation prevents oxidized low-density lipoprotein-mediated vascular injury.
    Balla J, Belcher JD, Balla G, Jacob HS, Vercellotti GM.
    Trans Assoc Am Physicians; 1993 Jan; 106():128-33. PubMed ID: 8036736
    [Abstract] [Full Text] [Related]

  • 13. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
    Lobo J, Santos F, Grosso D, Lima R, Barreira AL, Leite M, Mafra D, Abdalla DS.
    Nephron Clin Pract; 2008 Jan; 108(4):c298-304. PubMed ID: 18434752
    [Abstract] [Full Text] [Related]

  • 14. The effect of vitamin E and vitamin C supplementation on LDL oxidizability and neutrophil respiratory burst in young smokers.
    Fuller CJ, May MA, Martin KJ.
    J Am Coll Nutr; 2000 Jun; 19(3):361-9. PubMed ID: 10872898
    [Abstract] [Full Text] [Related]

  • 15. Vitamin E supplementation in hyperlipidaemic patients: effect of increasing doses on in vitro and in vivo low-density lipoprotein oxidation.
    Wen Y, Killalea S, Norris LA, Cooke T, Feely J.
    Eur J Clin Invest; 1999 Dec; 29(12):1027-34. PubMed ID: 10583450
    [Abstract] [Full Text] [Related]

  • 16. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M, Tazza L, Merki E, Giungi S, Luciani G, Miller ER, Lin EB, Tortorelli A, Tsimikas S.
    Blood Purif; 2007 Dec; 25(5-6):457-65. PubMed ID: 18075247
    [Abstract] [Full Text] [Related]

  • 17. [Effect of vitamin E supplementation on the vitamin content of lipoprotein in young men and women].
    Somogyi A, Herold M, Kocsis I, Nagy G, Somfai G, Studinger P.
    Orv Hetil; 2005 Aug 28; 146(35):1813-8. PubMed ID: 16187540
    [Abstract] [Full Text] [Related]

  • 18. Positive association between plasma levels of oxidized low-density lipoprotein and myeloperoxidase after hemodialysis in patients with diabetic end-stage renal disease.
    Kitabayashi C, Naruko T, Sugioka K, Yunoki K, Nakagawa M, Inaba M, Ohsawa M, Konishi Y, Imanishi M, Inoue T, Itabe H, Yoshiyama M, Haze K, Becker AE, Ueda M.
    Hemodial Int; 2013 Oct 28; 17(4):557-67. PubMed ID: 23627905
    [Abstract] [Full Text] [Related]

  • 19. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI, Schreier L, Elbert A, Berg G, Beresan H, López G, Wikinski R.
    Metabolism; 2003 Jan 28; 52(1):116-21. PubMed ID: 12524671
    [Abstract] [Full Text] [Related]

  • 20. Paraoxonase enzyme activity is enhanced by zinc supplementation in hemodialysis patients.
    Rahimi-Ardabili B, Argani H, Ghorbanihaghjo A, Rashtchizadeh N, Naghavi-Behzad M, Ghorashi S, Nezami N.
    Ren Fail; 2012 Jan 28; 34(9):1123-8. PubMed ID: 22950600
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.